Coronavac 600,0 SU SUSPENSION FOR INJECTION
PDF Leaflet Revision Date: 09 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunisation to prevent COVID-19 in individuals 3 to 59 years.
Dosage (summary)
Adults: 2 doses of 0.5 ml each, 14-28 days apart.
Onset of Action / Duration
Onset: 14 days after first dose, Duration: Unknown.
Special Populations
- Immunocompromised individuals
- Severe neurological conditions
- Thrombocytopenia
- Coagulation disorders
Pregnancy & Breastfeeding
Limited data; safety during pregnancy and lactation not established.
Key Drug Interactions
- No interaction studies performed
- Concomitant administration with other vaccines not studied
Contraindications
- Hypersensitivity to inactivated SARS-CoV-2 virus or excipients
Common side effects
- Injection-site pain
- Headache
- Fatigue
- Muscle pain
- Diarrhoea
- Nausea
Counselling Points
- Record vaccine name and batch number
- Avoid mixing with other vaccines
- Report any adverse reactions
Serious warnings
- Anaphylaxis risk
- Monitor for 15 mins post-injection
- Caution in severe neurological disorders
Important Disclaimer
The Coronavac 600,0 SU SUSPENSION FOR INJECTION professional information leaflet below is the property of Curanto Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
